Similar drugsTo uncover
Dosage form: & nbspSuspension for subcutaneous administration
Composition:In 1 dose (0.5 ml) contains: (10 ± 1) μg hemagglutinin of influenza virus serotype A (H1N1), (10 ± 1) μg hemagglutinin of influenza virus serotype A (H3N2) and (13 ± 1) μg hemagglutinin of influenza type B virus. Stabilizer-albumin solution for infusions of 10 and 20%. Preservative - thiomersal (merthiolate) - (50 ± 7.5) μg. Does not contain antibiotics.
The antigenic composition of the vaccine changes every year in accordance with the epidemic situation, the recommendations of the WHO and the Commission on influenza vaccine and diagnostic strains.
Description:

Opalescent suspension of light gray color, not containing flakes and foreign inclusions.

Pharmacotherapeutic group:MIBP vaccine
ATX: & nbsp
  • Vaccine for the prevention of influenza
  • Indications:

    Prevention of influenza in adults over 18 years.

    Contraindications:
    1. Allergic reactions to chicken eggs and hypersensitivity to chicken protein.
    2. Reaction or post-vaccination complication of previous administration of seasonal influenza vaccines.
    3. Acute infectious and non-infectious diseases, chronic diseases in the acute stage - vaccinations are carried out not earlier than a month after recovery (remission).For non-severe acute respiratory viral infections, acute intestinal diseases, vaccination is carried out after normalizing the temperature
    4. Systemic diffuse diseases of connective tissue.
    5. Diseases of the adrenal glands.
    6. Hereditary, degenerative and progredient diseases of the nervous system.
    7. Pregnancy and lactation.
    The possibility of vaccination of persons suffering from chronic diseases not listed in the list of contraindications is determined by the attending physician based on the patient's condition.
    Pregnancy and lactation:The use is contraindicated.
    Dosing and Administration:

    Vaccinations are carried out in the autumn-winter period. Annual vaccination is recommended first of all for people with a high risk of complications and people who are at a higher risk of influenza infection or other people: people over 60; persons suffering from chronic physical illness; often ill ARI; medical workers; employees of the service sector, transport, educational institutions.

    The vaccine is administered once, subcutaneously, at a dose of 0.5 ml, to the area of ​​the outer surface of the shoulder a few centimeters below the shoulder joint.

    Before using the ampoule with the drug should be shaken carefully.

    Not suitable for use in drug vials with compromised integrity or marking, changing the physical properties (color, clarity, homogeneity) with the expired term of validity, improper storage.

    Opening of ampoules and the vaccination procedure are carried out with strict adherence to aseptic and antiseptic rules.

    The drug in the opened ampoule is not subject to storage.

    The vaccination is recorded in the prescribed registration forms with the date of administration of the drug, dose, serial number and name of the manufacturer.

    Precautions for use.

    All persons subject to inoculations should be examined by a doctor taking into account anamnestic data. On the day of vaccination, the vaccinated should be examined by a physician with mandatory thermometry. At a temperature above 37 ° C vaccination is not carried out. The doctor is responsible for the correct administration of the vaccine.

    After vaccination, the vaccinated should be under medical supervision for at least 30 minutes. Place of vaccination should be provided with anti-shock therapy.

    Side effects:With the introduction of the drug, a part of the vaccinated can see general reactions - in the form of malaise, headache, fever.Not more than 3% of reactions over 37.5 ° С (including no more than 0.5% over 38.5 ° С), registered in the first two days after immunization, duration not more than three days are allowed. Local reactions (hyperemia and puffiness) occur in most of the vaccinated; a part of the vaccinated can form. limited infiltrates. The development of an infiltrate up to 50 mm is allowed in no more than 3%. The duration of local reactions does not exceed 5 days.
    Overdose:Cases of overdose are not established.
    Interaction:The flu vaccine can be used concomitantly with other vaccines of the National Schedule of Prophylactic Inoculations and inactivated vaccines of the preventive vaccination calendar for epidemic indications administered by an adult. This should take into account contraindications to each of the vaccines used, the drugs must be injected into different parts of the body with different syringes.
    Effect on the ability to drive transp. cf. and fur:

    Not installed.

    Form release / dosage:

    Suspension for subcutaneous administration.

    Packaging:For 0.5 ml (1 dose) in ampoules or disposable syringes.

    For 10 ampoules in a cardboard box along with the instructions for use and ampoule scalper

    5 ampoules in the outline of the cell. 2 contour squares in a pack of cardboard together with an instruction for use and a scarifier ampoule.

    When packaging ampoules that have a break ring or a point for dissection, the ampoule scapegrator is not inserted.

    1 syringe in a planar cell package. 1 contour pack in a pack of cardboard along with instructions for use.

    Storage conditions:

    Conditions of storage and transportation. Store in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C in a place inaccessible to children. Freezing is not allowed.

    Transport in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ° C, freezing is not allowed.
    Shelf life:Shelf life 1 year. The drug is not eligible for use with expired use.
    Terms of leave from pharmacies:For hospitals
    Registration number:LS-000484
    Date of registration:06.07.2010 / 27.05.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:MICROGEN FGUP Scientific and Production Association MICROGEN FGUP Scientific and Production Association Russia
    Manufacturer: & nbsp
    Information update date: & nbsp12.01.2017
    Illustrated instructions
      Instructions
      Up